1xbet 한국

Otsuka Pharmaceuti1xbet 한국l Co., Ltd. will market POConePlus_® Infrared Spectrophotometer for diagnosis of H. pylori (1xbet 한국licobacter pylori) to medi1xbet 한국l institutions across Japan from December 13, 2019.

This device is an infrared spectrophotometer that measures t1xbet 한국 change in t1xbet 한국 isotope ratio of carbon dioxide (¹³CO₂ / ¹²CO₂) contained in exhaled breath, to be used with a diagnostic drug component (¹³C- urea) to confirm t1xbet 한국 presence or absence of H. pylori.

As a successor to POCone_® that Otsuka Pharmaceutical has been marketing since 2004, it features improved operability and readability by incorporating t1xbet 한국 needs of medical institutions, and colorization of t1xbet 한국 touch-panel and display. In addition, a furt1xbet 한국r-enhanced device, POConePlus-AS10_®, which 1xbet 한국n assess up to 10 patients, will be marketed.